Cargando…
Dysphagia Causes Symptom Fluctuations after Oral L-DOPA Treatment in a Patient with Parkinson Disease
OBJECTIVE: The causes of “delayed-on” and “no-on” phenomena in Parkinson disease (PD) are thought to have some impact on the progress of L-DOPA from the time of ingestion until it reaches the brain and is converted to dopamine. Dysphagia can cause fluctuating symptom expression in L-DOPA therapy for...
Autores principales: | Sato, Hiromasa, Yamamoto, Toshiyuki, Sato, Masako, Furusawa, Yoshihiko, Murata, Miho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903165/ https://www.ncbi.nlm.nih.gov/pubmed/29681829 http://dx.doi.org/10.1159/000488138 |
Ejemplares similares
-
Validation of the Japanese translation of the Dysphagia Handicap Index
por: Oda, Chihiro, et al.
Publicado: (2017) -
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023) -
Molecular Effects of L-dopa Therapy in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2014) -
Beyond L-DOPA: hope for Parkinson’s treatment and diagnosis
Publicado: (2017) -
L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017)